Correlation Between Keros Therapeutics and Merus BV

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Keros Therapeutics and Merus BV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Keros Therapeutics and Merus BV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Keros Therapeutics and Merus BV, you can compare the effects of market volatilities on Keros Therapeutics and Merus BV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Keros Therapeutics with a short position of Merus BV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Keros Therapeutics and Merus BV.

Diversification Opportunities for Keros Therapeutics and Merus BV

0.4
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Keros and Merus is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Keros Therapeutics and Merus BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merus BV and Keros Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Keros Therapeutics are associated (or correlated) with Merus BV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merus BV has no effect on the direction of Keros Therapeutics i.e., Keros Therapeutics and Merus BV go up and down completely randomly.

Pair Corralation between Keros Therapeutics and Merus BV

Given the investment horizon of 90 days Keros Therapeutics is expected to under-perform the Merus BV. But the stock apears to be less risky and, when comparing its historical volatility, Keros Therapeutics is 1.23 times less risky than Merus BV. The stock trades about -0.02 of its potential returns per unit of risk. The Merus BV is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  4,848  in Merus BV on August 27, 2024 and sell it today you would lose (299.00) from holding Merus BV or give up 6.17% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Keros Therapeutics  vs.  Merus BV

 Performance 
       Timeline  
Keros Therapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Keros Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Keros Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Merus BV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merus BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Keros Therapeutics and Merus BV Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Keros Therapeutics and Merus BV

The main advantage of trading using opposite Keros Therapeutics and Merus BV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Keros Therapeutics position performs unexpectedly, Merus BV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merus BV will offset losses from the drop in Merus BV's long position.
The idea behind Keros Therapeutics and Merus BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Stocks Directory
Find actively traded stocks across global markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device